US authorities on Tuesday approved the first medication designed specifically to treat post-partum depression, an illness that affects about one in nine new American mothers.
The drug is called brexanolone from a company called Sage Therapeutics and one advantage is that it works quickly, in two days, whereas traditional anti-depressants can take weeks or months to kick in.Full Story
Eleven people have died and more than 30,000 have been infected this year in a major outbreak of measles in Ukraine, the European country worst hit by the disease, Kiev said Monday.Full Story
In a city battered by quakes, Christchurch's medics were tragically well-schooled in tackling mass casualty events -- but none could have prepared for the injuries unleashed by a white supremacist with assault rifles bent on mass murder.Full Story
The latest U.S. research on eggs won't go over easy for those who can't eat breakfast without them.Full Story
Long-term exposure to harmful smog particles increases the risk of diabetes, a new study in China has shown, providing evidence for a link between the country's air pollution and the disease.Full Story
A dozen newborn babies whose deaths at a Tunisian state hospital sparked public outrage are believed to have been killed by an infection acquired in the clinic, the acting health minister said Monday.Full Story
Tunisia's health minister has resigned after the sudden deaths of 11 newborn babies at a state maternity hospital sparked an outcry in the country, the government said.
Prime Minister Youssef Chahed accepted Abderraouf Cherif's resignation, the premier's office said on Facebook late on Saturday.Full Story
Bhutanese conjoined twins Nima and Dawa Pelden made a triumphant return to their home country on Thursday, able for the first time in their lives to move around without falling over each other.Full Story
Explosives left behind by the Islamic State group in Iraq's Mosul took 12-year-old Abdallah's left leg, but another kind of terror may cost him his arm: antibiotic-resistant bacteria.Full Story
US regulators on Tuesday approved the sale of a new drug that could revolutionize the treatment of severe depression, giving new hope to sufferers who have not found an effective option.Full Story